Bone Allografts Market - Introduction
Bone allografts are being widely used in dentistry. The preparation and processing for safe use and effective graft material needs an experience clinicians who can handle and place the allografts in the right position. Antigenicity and risk of disease transmission from donor to recipient are major concerns associated with the materials. Bone allografts are also utilized in other kind of surgery involving bone from minor defects to major bone loss after tumor resection. Bone allografts have been employed as a natural substitute to repair skeletal defects. They are an attractive alternative to bone autografts, as their supply is less limited as the allografts allow structural restoration of the skeleton, and their surfaces support bone formation. The principle involved in successful bone grafts include osteoconduction, osteoinduction, and osteogenesis.
Usage of bone allografts has evolved in the last few decades. These devices provide the ability to create more bone volume, both in horizontal and vertical directions, making primary stability possible for patients. Increase in incidence of dental problems and rise in adoption of grafts for surgery are projected to increase the preference of physicians to treat patients with bone allografts. Moreover, technological progress in the design of bone allografts and development of multifunctional tools in handling allografts for better positioning are paving the way for early diagnosis and treatment of dental & skeletal problems.
Need an Overview of the Report on Bone Allografts Market? Ask for the Brochure here
Bone Allografts Market - Competitive Landscape
Major players operating in the global bone allografts market include Biomatlante, Stryker, Ortho Solutions Inc., Zimmer Biomet, B. Braun Melsungen, Depuy Synthes, and Cook Medical.
Established in 1941, Protek Devices LP is located in the Kalamazoo, U.S. Stryker Corporation offers a comprehensive portfolio of solutions for primary, revision knee, and partial hip anthroplasty. The company’s implants are designed to provide surgeons with multiple options to treat patients with osteoarthritis.
Stryker Corporation’s product portfolio includes implants utilized in joint replacement and trauma surgeries, surgical equipment and neurosurgical, neurovascular, and spinal devices as well as other medical devices employed in diverse medical specialties.
Zimmer Biomet Holdings.
Established in 1927, Zimmer Biomet Holdings is located in Warsaw, U.S. The company develops, produces, and distributes a wide range of joint replacement products and surgical solutions that cater to health care institutions across the globe.
Zimmer Biomet recorded net sales of US$ 6.0 Bn in 2015, reflecting 35% constant currency revenue. The merger of Zimmer and Biomet is likely to further enhance and diversify the company’s offerings to provide a diverse portfolio of solutions for musculoskeletal health.
Bone Allografts Market Dynamics
High prevalence of osteoporosis and dental problems driving demand for bone allografts
High prevalence of osteoporosis and dental problems is a major factor driving the global bone allografts market. Increase in incidence of periodontal diseases among young adults, rise in demand for orthopedic bone allografts and casting materials, especially among the geriatric population, are other factors that are anticipated to propel the global market.
Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Bone Allografts Market” here
Increasing number of revision arthroplasties procedures among geriatric population driving the bone allografts market
The number of revision arthroplasties carried out in the geriatric population is increasing. The newer trend of minimally-invasive surgery, particularly in the spine where the need for bone grafts or substitutes is increasing rapidly, is likely to drive the demand for bone allografts in the near future.
According to the World Health Organization, the global population aged 85 years and above is estimated to increase by 351% in the next 40 years. According to Springer Nature’s Osteoporosis International, around 158 million people aged 50 years and above are prone to developing bone fractures. The research further stated that bone fractures could double by 2040. These factors are likely to drive the bone allografts market in the near future.
High inflammation and infection rate after surgery restraining bone allografts market
Inflammation resulting in chronic complications after dental surgery carried out by using bone allografts is a key factor hampering the bone allografts market. However, companies are focusing on the development of new bone allografts that provide less complication or inflammation owing to the rising demand for bone allografts among consumers. Moreover, experience clinicians or surgeons should be prescribed for orthopedic surgeries using bone allografts, as misplacing the allografts and high volume of allograft can lead to patient inflammation rate or death. This is also likely to restrain the adoption of bone allografts for orthopedic surgery.
Bone Allografts Market - Segmentation
Based on product type, the bone allografts market can be segmented into
- Fresh/Frozen Bone
Based on application, the bone allografts market can be classified into
- Sports Surgery
- Reconstruction & Traumatology
In terms of end-use industry, the bone allografts market can be segregated into
- Orthopedic Clinics
- Dental Clinics
- Aesthetics Clinics
- Ambulatory Care Centers
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.